Studies on chemical constituents
of Camellia oleifera Abel
Li Bin, Luo Yongming
(Jiangxi College of Traditional Chinese Medicine, pharmacy department,
Nanchang 330006)
Received on Oct. 25, 2002; Supported
by the National Natural Science Foundation of China (No.29862002)
Abstracts
In this paper, the chemical constituents in seeds cake of Camellia oleifera Abel
were well studied, and seven monocases were firstly isolated, on the basis of
its spectral and physicochemical evidence, the structures of these compounds were
elucidated to be: Dimethylterephthalate (I), p-Hydroxybenzoic acid (II),
Kaemferol (III), Kaemferol-3-O-a-L-rhamnopyranosyl(1¡ú6)-b-D-glucopyranoside(IV), Kaemferol-3-O-[2-O-b-D-glucopyranosyl-6- O-a-L-rhamnopyranosyl]-b-D-glucopyranoside(V),
Kaemferol-3-O-[2-O-b-D-xylopyranosyl-6-O-a-L- rhamnopyranosyl]-b-D-glucopyranoside (VI),
Kaemferol-3-O-[2-O-a-L-
rhamnopyranosyl-6-O-b-D-xylopyranosyl]-b-D-glucopyranoside (VII). These
compounds were first isolated and obtained from this plant.
Keywords Camellia
oleifera; chemical constituents ; elucidation
Camellia oleifera Abel is a plant of
Theaceae, it is an important oil material in China. Its oil is used to treat
intestinal disorders;its roots can be used to treat stomach-ache, facial and
external injury;and its defatted seeds cake can treat injury, kill four pests
and field snails. While it is prescribed, there are many chemical constituents in
the defatted seeds of Camellia oleifera Abel, such as saponins, flavonols. Yet,
up to now there has no monocase been reported.For the sake of elucidating its
bioactive constituents, exploiting its medical values and advancing its integrative usage,
defatted seeds cake of Camellia oleifera Abel had been well investigatied,
and, seven compounds were isolated , their structures were identified on the basis
of its chemical and spectral evidence, which are: Dimethylterephthalate(I),
p-Hydroxybenzoic acid(II) , Kaemferol (III), Kaemferol-3-O-rhamno-pyranosyl
(1¡ú6) glucopyranoside (IV),
Kaemferol-3-O-(2-O-glucopyranosyl-6-O-rhamnopyranosyl)-glucopyranoside (V),
Kaemferol-3-O-(2-O-xylopyranosyl-6-O-rham-nopyranosyl)-glucopyranoside (VI),
Kaemferol-3-O-(2-O-rhamnopyranosyl-6-O-xylopyranosyl)-glucopyranoside(VII). These
compounds were first obtained from this plant.
1 INSTRUMENTS AND MATERIALS
General UV and IR spectra values were measured with a DU-650 and a FT-IR 2000
spectrophotometer, 1H- and 13C-NMR spectra were recorded on a
INOVA-500 spectrometers.Chemical shifts are expressed as the value, using TMS as an
internal standard. RSI-MS data were measured with VG ZAB-HS mass spectrometer, Preparative
HPLC was done with Dionex system (Pump 580, 340SDAD
diode arrays, YWG-C18column: F=10um, 10¡Á20mm,
detection, UV 250nm); defatted seeds cake of
Camellia oleifera were bought from Jiangxi Haitian Co.
2 EXTRACTION AND ISOLATION
The defatted seeds cake of Camellia oleifera Abel were broken into pieces, and
extracted with boiling water for 3 times.After filtration , the water extract was
concentrated, and the concentrate was extracted with EtOAc and BuOH in turn. The EtOAc
layer was evaporated, and the extract was fractionated by silica gel column
chromatography(eluation system: CHCl3-EtOAc), 2 white needle crystals and
1 yellow crystals were obtained from the eluate.After recrystallization, compound I (80mg), II(130mg) and III(500 mg) were obtained.The BuOH layer was also evaporated,
and the extract was subjected to macroreticular resin column chromatography first(eluation
system:EtOH-Water), and 40% EtOH eluate was collected and fractionated by column
chromatography(eluation system:EtOH-Water), 4 crude yellow crystals were obtained ,
which were repurified by preparative HPLC(eluation system:BuOH-Water) to give 4
constituents , namely compound IV(70mg), V(6mg), VI(10mg), VII(5mg).
3 ELUCIDATION
Compound I Compound Iwas isolated as white needle crystals with a mp of 141-143ºC, and the molecular formula C10H10O4
.UV lmaxnm(MeOH): 201, 241,
285, 314. IR(KBr) nmaxcm-1
:3017, 2960, 1961, 1719 (C=O), 1537(benzene ring), 1504(benzene ring), 1434, 1280, 1263, 1107£¬1017, 954, 731. EI-MSm/z(%):194(M+, 37), 179(M-CH3,
10), 163(M-OCH3, 100), 135 (M-COOCH3, 30), 120(M-COOCH3-CH3,
15), 103(M-COOCH3-OCH3, 22), 92(7), 76(C6H4+,
21), 66(9). 1H-NMR(CDCl3) dppm:8.1(4H£¬S), 3.9(6H, S).On
the basis of its spectral data, compound I was:
Dimethylterephthalate.
Compound II Compound II was a white needle crystal with a mp of 216-218¡æ, and the molecular
formula C7H6O3. UV lmaxnm(EtOH):252. IR(KBr)nmaxcm-1:3435(OH), 2936, 2866, 1736(C=O), 1462(benzene ring), 1380 (C-H), 1059 (C-O-C), 959, 801. EI-MS
m/z(%)£º138(M+,
90), 121 (M-OH,
100), 93(M-COOH,
35), 77(C6H5+,
15), 65(C5H5+,
35), 45(-COOH,
100), 39(38).1H-NMR(CD3OD)dppm:6.8(2H, m, J=14Hz, 3Hz, 2.5Hz, H-3,
H-5), 7.8(2H, m, J=14Hz, 3Hz, 2.5Hz, H-2,
H-6). 13C-NMR(CD3OD)dppm: 116.0(C-3, C-5), 122.7(C-1), 133.0(C-2, C-6), 163.4(C-4), 170.1(-COOH). Upon its spectral evidence , its structure should be
p-Hydroxybenzoic acid.
Compound III Compound III was isolated as yellow crystals with a mp of 275-277ºC, and the molecular formula C15H10O6.
UV lmaxnm
(MeOH)365, 327sh, 294sh, 265, 253sh. IR(KBr) nmaxcm-1 :3747(-OH, sharp band),
3321(-OH, broad band), 2463, 2364, 1654(C=O), 1607(benzene ring), 1503(benzene
ring), 1378, 1180, 1101, 985, 820. EI-MS m/z(%): 286(M+, 100), 270, 258(M-CO,
27), 229(M-CO-CO, 25), 213(18), 153(A1+H, 21), 121(B2+,
60), 93(C6H5O+, 22), 77(C6H5+,
18), 69(30).1H-NMR (CD3COCD3)
dppm:6.2(1H, d, J=2Hz, C6-H), 6.5(1H, d,
J=2Hz, C8-H), 7.0(2H, dd, J=9Hz, 3Hz, H-3, H-5'), 8.1(2H, dd,
J=9Hz, 3Hz, H-2', H-6'). Its data of 13C-NMR(CD3OD)
were in the table 1 .On the basis of relevant reference[1]and its spectral
data, compound III
is 3, 5, 7, 4'-Tetrahydroxyflavone, namely Kaemferol.
Compound IV Compound IV was a yellow crystal with a mp of 223-224ºC, and the molecular formula C27H30O15
. UV lmaxnm
(MeOH):351(band I), 319sh, 265(band II); lmaxnm (MeOH+NaOAc):383(band
I), 352, 305sh, 273(band II). IR(KBr)nmaxcm-1 :3425(OH),
2930, 2361, 1684(C=O), 1563(benzene ring), 1507(benzene ring).1180(C-O), 887, 831, 582.
FAB-MS m/z(%): 595(M+H, 27), 449(M-rha+H, 12), 287(Kaemferol+H, 44),
113(100), 87(14), 59(8). 1H-NMR (CD3OD) dppm:8.1(2H, d, J=7.5Hz, H-2',
H-6'), 6.9(2H, d, J=7.5Hz, H-3', H-5'), 6.4(1H, s, H-8),
6.2(1H, s, H-6), 5.2(1H, d, J=7Hz, glc-H-1), 4.5(1H, s, rha-H-1),
3.2-3.8(10H£¬m£¬rha- and glc-H), 1.3-1.7(3H£¬m£¬rha-CH3). Its
data of 13C-NMR(CD3OD) are in the Table 1 and Table 3. Because 6-C
of glucose in 13C-NMR dropped from 60.8 to 68.6ppm, due to the glycosylation
shift, rhamnose should link to 6-C of glucose, so it was Kaemferol-3-O-a-L-rhamnopyranosyl(1¡ú6)-b-D-glucopyranoside[1,
2].
Compound V Compound V was isolated as light-yellow crystals, and the molecular formula C33H40O20.
UV lmaxnm
(MeOH):346(band I), 265(band II);lmaxnm (MeOH+NaOAc);358(band I), 335, 271(band II).IR(KBr)maxcm-1:
3401(-OH, broad band), 2929(CH2), 1712(C=O), 1654(benzene ring), 1608(benzene
ring), 1364, 1178, 1075(C-O), 842. RSI-MSm/z(%): 757(M+H, 70), 595(M-glc+H, 30),
449(M-glc-rha+H, 35), 287(Kaemferol+H, 100). 1H-NMR(DMSO-d6) dppm:12.6(1H, s, -OH), 9.5(1H, s, -OH),
8.0(2H, d, J=8.7Hz, H-2', H-6'), 6.9 (2H, d, J=8.7Hz, H-3',
H-5'), 6.4(1H, s, H-8), 6.2(1H, s, H-6), 5.6(1H, d, J=7Hz, glc-H-1''),
5.4(1H, m, glc-H-1''''), 4.6(1H, m, rha-H-1'''), 3.0-4.3(13H, m,
2glc-and rha-H), 0.8-1.4(3H, m, rha-CH3).
Its data of 13C-NMR(CD3OD) are in the Table1 and Table3. Acid
hydrolysis of Compound V with 5% H2SO4
provided L-rhamnose, and D-glucose. According to relevant reference[3, 4],
compound V was elucidated as: Kaemferol-3-O-[2-O-b-D-glucopyranosyl-6-O-a-L-rhamnopyranosyl]-b-D-glucopyranoside.
Compound VI Compound VI was isolated as yellow crystals, and the molecular formula C32H38O19.
UV lmaxnm
(MeOH):347(band I), 266(band II); lmaxnm
(MeOH+NaOAc):353(band I), 339(sh), 273(band II). IR nmaxcm-1 :3402(-OH, broad band), 2931,
1718(-CO), 1610(benzene ring), 1263, 1077(C-O-C), 892.
RSI-MSm/z(%):727(M+H, 39), 595(M-xyl+H, 30), 449(M-xyl-rha+H, 10),
287(Kaemferol+H, 100). 1H-NMR(DMSO-d6) dppm: 9.5(1H, s, -OH), 8.0(2H, d, J=8.5Hz, H-2', H-6'),
6.9(2H, d, J=8.5Hz, H-3', H-5'), 6.4(1H, s, H-8), 6.2(1H,
s, H-6), 5.3(1H, d, J=7Hz, glc-H-1''), 5.0(1H, m, xyl- H-1'''),
4.6(1H, m, rha-H-1''''), 3.1-4.4(13H, m, glc-, xyl-
and rha-H), 0.8-1.8(3H, m, rha-CH3). Its
data of 13C-NMR(CD3OD) are in the Table 1 and Table 3.Acid
hydrolysis of Compound VI with 5% H2SO4
provided L-rhamnose, D-glucose and D-xylose. Compared relevant reference[3-6]
with its spectral evidence, compound VI is Kaemferol-3-O-[2-O-b-D-xylopyranosyl-6-O-a-L- rhamno-pyranosyl]-b-D-glucopyranoside.
Compound VII Compound VII was got as yellow crystals, and the molecular formula C32H38O19.
UV lmaxnm
(MeOH):349(band I), 266(band II); lmaxnm
(MeOH+NaOAc):358(band I), 334(sh), 271(band II). IRnmaxcm-1: 3413(-OH, broad band), 2929,
1718(C=O), 1610(benzene ring), 1376, 1263, 1077(C-O-C), 893. RSI-MS m/z(%):727(M+H,
7), 581(M-rha+H), 449(M-rha-xyl+H, 10), 287(Kaemferol+H, 100). 1H-NMR(DMSO-d6) dppm:9.5(1H, s, -OH), 8.0(2H, d,
J=8.3Hz, H-2', H-6'), 6.9(2H, d, J=8.3Hz, H-3', H-5'), 6.4(1H, s,
H-8), 6.2(1H, s, H-6), 5.3 (1H, d, J=7Hz, glc-H-1''), 5.0(1H, m,
xyl-H-1''''), 4.6(1H, m, rha-H-1'''), 3.1-4.4(13H, m,
glc-, xyl- and rha-H), 0.8-1.8(3H, m, rha-CH3).
The data of 13C-NMR(CD3OD)were in the Table 1 and Table 3. Acid
hydrolysis of Compound VI with 5% H2SO4
provided L-rhamnose and D-glucose, D-xylose. Compared its spectral evidence to
relevant reference[3-6] , its structrue is
Kaemferol-3-O-[2-O-a-L-
rhamnopyranosyl-6-O-b-D-xylopyranosyl]-b-D-glucopyranoside .
Table 1 Comparing
exerperimental data of 13C-NMR of aglycone in compound III, IV, V, VI, VII
with the references.
|
Kaempferol |
Compound IV |
Compound V |
Compound VI |
Compound
VII |
C |
Reference
(DMSO-d6) |
Experiment
(CD3OD) |
Experiment
(CD3OD) |
Experiment
(DMSO-d6) |
Experiment (DMSO-d6) |
Experimen
(DMSO-d6) |
2
3
4
5
6
7
8
9
10
1
2
3
4
5
6 |
146.7
135.7
175.8
156.2
98.2
163.8
93.4
160.7
103.0
121.7
129.5
115.4
159.2
115.4
129.5 |
147.0
136.4
176.4
157.6
99.0
165.1
94.3
161.8
103.9
123.0
130.3
116.2
160.2
116.2
130.3 |
158.6
135.5
179.4
159.4
99.9
166.1
95.0
163.0
105.7
122.7
132.4
116.1
161.5
116.1
132.4 |
149.5
133.5
178.1
160.4
100.6
167.1
95.4
165.1
107.2
123.7
132.5
116.7
162.5
116.7
132.5 |
149.8
134.0
180.4
158.1
100.9
168.0
96.2
164.3
107.0
124.2
133.1
117.0
162.0
117.0
133.1 |
149.1
134.8
180.4
158.4
100.7
168.1
96.2
165.0
106.7
124.7
133.6
117.2
161.5
117.2
133.6 |
Table 2 The data of
13C NMR of
three sugar in the references. (K means kaemferol)
C |
K-3-O-glc |
K-3-O-rha |
b-D-glc |
a-L- rha |
b-D-xyl |
1
2
3
4
5
6 |
100.8
74.1
77.3
69.8
76.3
60.8 |
101.9
70.0
70.6
71.2
69.8
17.3 |
96.8
75.2
76.7
70.1
76.7
61.8 |
94.8
71.8
71.0
73.2
69.1
17.7 |
97.5
75.1
76.8
70.2
66.1 |
Table 3
Experimental data of 13C NMR of sugars in compound IV, V, VI,
VII
|
Compound IV
(CD3OD) |
Compound V
(DMSO-d6) |
Compound VI
(DMSO-d6) |
Compound VII
(DMSO-d6) |
C |
b-D-glc |
a-L- rha |
glc 1 |
rha |
glc 2 |
glc |
rha |
xyl |
glc |
xyl |
rha |
1
2
3
4
5
6 |
104.6
75.8
77.2
71.4
78.1
68.6 |
102.4
72.1
72.3
73.9
69.7
17.9 |
104.8
76.8
78.1
72.5
79.2
68.0 |
103.4
79.4
70.3
71.9
69.7
17.9 |
105.2
73.7
76.1
69.4
76.1
60.6 |
104.6
76.5
77.8
72.2
78.5
68.0 |
102.7
79.1
71.3
71.9
70.6
17.7 |
105.5
76.8
78.8
73.4
66.2 |
105.6
76.2
77.0
72.6
78.9
68.4 |
107.0
82.0
77.8
73.8
66.9 |
101.9
70.1
70.3
72.9
68.3
18.0 |
REFERENCES
[1] Wang Zhixue, Zhang Yongyu, Liu Mingsheng
et al. Journal of shenyang college of pharmacy (Shenyang Yaoxueyuan Xuebao),
1985, 2 (4): 284.
[2] Cheng Guiren, Jin Jinglan, Wen Yongxin. Acta pharmaceutica sinica (Yaoxue Xuebao), 1987, 22 (3):
203.
[3] Xiao Chonghou. Chemistry of Chinese herbs (Zhongyao Huaxue). Shanghai: Shanghai
scientific technology publishing house, 1996: 180.
[4] Yu Rongming, LiXian, ZhuTingru. Journal of shenyang college of pharmacy
(Shenyang Yaoxueyuan Xuebao), 1989, 6 (1): 58.
[5] WangYongqi, Lu Lin, JiangYang et al. Chinese traditional and herbal drugs
(Zhong Chaoyao), 1992,
23 (7): 341.
[6] Si Jianyong, Chen Dihua, Changqi et al. Acta pharmaceutica sinica (Yaoxue Xuebao), 1994,
29 (2): 158.
¡¡
|